ATOR-4066, a Neo-X-Prime bispecific antibody targeting CD40 and CEA, activates myeloid cells in primary human tumors in vitro and induces anti-tumor immunity in vivoKarin Hagerbrand,Anette Sundstedt,Mattias Levin,Yago Pico de Coana, Laura Varas, Lill Ljung,Anneli Nilsson,Mona Celander,David Gomez Jimenez, Hampus Andersson,Malin Lindstedt,Peter EllmarkCANCER RESEARCH（2023）引用 0|浏览3暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
